BYTAZRA Trademark

Trademark Overview


On Thursday, March 24, 2022, a trademark application was filed for BYTAZRA with the United States Patent and Trademark Office. The USPTO has given the BYTAZRA trademark a serial number of 97329663. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 11, 2024. This trademark is owned by Synermore Biologics (Suzhou) Co., Ltd.. The BYTAZRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the post-exposure preventive treatment or treatment of rabies; Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the post-exposure preventive treatment or treatment of rabies; Veterinary preparations for dogs or cats for the post-exposure preventive treatment or treatment of rabies; Veterinary pharmaceutical preparations for the treatment of rabies; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Biological preparations for the post-exposure preventive treatment or treatment of rabies; Syringes sold filled with Zamerovimab and Mazorelvimab; Vaccines; Blood for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Chemical reagents for medical ...
bytazra

General Information


Serial Number97329663
Word MarkBYTAZRA
Filing DateThursday, March 24, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the post-exposure preventive treatment or treatment of rabies; Pharmaceutical preparations and substances for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral infections; Chemical preparations for pharmaceutical or medical purposes, namely, for the post-exposure preventive treatment or treatment of rabies; Veterinary preparations for dogs or cats for the post-exposure preventive treatment or treatment of rabies; Veterinary pharmaceutical preparations for the treatment of rabies; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Biological preparations for the post-exposure preventive treatment or treatment of rabies; Syringes sold filled with Zamerovimab and Mazorelvimab; Vaccines; Blood for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Chemical reagents for medical or veterinary purposes; Reagent paper for medical purposes; Reagent paper for veterinary purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 30, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSynermore Biologics (Suzhou) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSuzhou 215000
CN

Party NameSynermore Biologics (Suzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSuzhou 215000
CN

Trademark Events


Event DateEvent Description
Monday, January 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 28, 2022NEW APPLICATION ENTERED
Wednesday, March 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 6, 2023ASSIGNED TO EXAMINER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 5, 2024SOU EXTENSION 2 GRANTED
Friday, April 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 5, 2024SOU EXTENSION 2 FILED
Wednesday, October 11, 2023SOU EXTENSION 1 FILED
Wednesday, October 11, 2023SOU EXTENSION 1 GRANTED
Saturday, April 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, November 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED